Literature DB >> 34507934

Interplay between endocrinology, metabolism and COVID-19 infection.

Sai Man Mung1, Edward B Jude2.   

Abstract

There are more than 170 million confirmed cases of COVID-19 worldwide, yet its effects on the endocrine system remain under-reported due to lack of awareness by the public, primary care givers and specialists. This is a narrative review using up-to-date literature discussing the consequences that infection with SARS-CoV-2 can have on diabetes and the endocrine glands including the adrenals, thyroid and pituitary, as well as hyponatremia and hypogonadism. Endocrinologists, internists and primary care physicians need to be aware of the involvement of the endocrine organs when dealing with people recovering from COVID-19 and actively manage any complications to reduce mortality and improve the quality of life of those affected. © Royal College of Physicians 2021. All rights reserved.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; adrenal; diabetes; endocrinology; hyponatraemia; metabolism; pancreas; pituitary; testes; thyroid

Mesh:

Year:  2021        PMID: 34507934      PMCID: PMC8439497          DOI: 10.7861/clinmed.2021-0200

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   5.410


  56 in total

1.  Angiotensin-(1-7), its receptor Mas, and the angiotensin-converting enzyme type 2 are expressed in the human ovary.

Authors:  Fernando M Reis; Daniela R Bouissou; Virginia M Pereira; Aroldo F Camargos; Adelina M dos Reis; Robson A Santos
Journal:  Fertil Steril       Date:  2010-08-01       Impact factor: 7.329

2.  Adrenal Insufficiency at the Time of COVID-19: A Retrospective Study in Patients Referring to a Tertiary Center.

Authors:  Giulia Carosi; Valentina Morelli; Giulia Del Sindaco; Andreea Liliana Serban; Arianna Cremaschi; Sofia Frigerio; Giulia Rodari; Eriselda Profka; Rita Indirli; Roberta Mungari; Veronica Resi; Emanuela Orsi; Emanuele Ferrante; Alessia Dolci; Claudia Giavoli; Maura Arosio; Giovanna Mantovani
Journal:  J Clin Endocrinol Metab       Date:  2021-03-08       Impact factor: 5.958

3.  Abdominal and testicular pain: An atypical presentation of COVID-19.

Authors:  Jesi Kim; Todd Thomsen; Naomi Sell; Andrew J Goldsmith
Journal:  Am J Emerg Med       Date:  2020-03-31       Impact factor: 2.469

4.  [Pituitary tumor resection in a patient with SARS-CoV-2 (COVID-19) infection. A case report and suggested airway management guidelines].

Authors:  Christiano Dos Santos E Santos; Luiz M da Costa Lima Filho; Cristiane A Tuma Santos; James S Neill; Henrique F Vale; Lakshmi N Kurnutala
Journal:  Braz J Anesthesiol       Date:  2020-06-09

5.  Thyroid function before, during and after COVID-19.

Authors:  Bernard Khoo; Tricia Tan; Sophie A Clarke; Edouard G Mills; Bijal Patel; Manish Modi; Maria Phylactou; Pei Chia Eng; Layla Thurston; Emma C Alexander; Karim Meeran; Alexander N Comninos; Ali Abbara; Waljit S Dhillo
Journal:  J Clin Endocrinol Metab       Date:  2020-11-12       Impact factor: 5.958

6.  Endocrinology in the time of COVID-19: Management of pituitary tumours.

Authors:  Maria Fleseriu; Olaf M Dekkers; Niki Karavitaki
Journal:  Eur J Endocrinol       Date:  2020-07       Impact factor: 6.664

7.  Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes.

Authors:  Jin-Kui Yang; Shan-Shan Lin; Xiu-Juan Ji; Li-Min Guo
Journal:  Acta Diabetol       Date:  2009-03-31       Impact factor: 4.280

8.  Dexamethasone in Hospitalized Patients with Covid-19.

Authors:  Peter Horby; Wei Shen Lim; Jonathan R Emberson; Marion Mafham; Jennifer L Bell; Louise Linsell; Natalie Staplin; Christopher Brightling; Andrew Ustianowski; Einas Elmahi; Benjamin Prudon; Christopher Green; Timothy Felton; David Chadwick; Kanchan Rege; Christopher Fegan; Lucy C Chappell; Saul N Faust; Thomas Jaki; Katie Jeffery; Alan Montgomery; Kathryn Rowan; Edmund Juszczak; J Kenneth Baillie; Richard Haynes; Martin J Landray
Journal:  N Engl J Med       Date:  2020-07-17       Impact factor: 91.245

Review 9.  Anosmia in COVID-19: Underlying Mechanisms and Assessment of an Olfactory Route to Brain Infection.

Authors:  Rafal Butowt; Christopher S von Bartheld
Journal:  Neuroscientist       Date:  2020-09-11       Impact factor: 7.519

Review 10.  COVID-19 and Neurological Impairment: Hypothalamic Circuits and Beyond.

Authors:  Bashair M Mussa; Ankita Srivastava; Anthony J M Verberne
Journal:  Viruses       Date:  2021-03-17       Impact factor: 5.048

View more
  3 in total

1.  In response to crisis, is versatility a reward or a necessity.

Authors:  Anton Emmanuel
Journal:  Clin Med (Lond)       Date:  2021-09       Impact factor: 5.410

Review 2.  The Relationship between COVID-19 and Hypothalamic-Pituitary-Adrenal Axis: A Large Spectrum from Glucocorticoid Insufficiency to Excess-The CAPISCO International Expert Panel.

Authors:  Mojca Jensterle; Rok Herman; Andrej Janež; Wael Al Mahmeed; Khalid Al-Rasadi; Kamila Al-Alawi; Maciej Banach; Yajnavalka Banerjee; Antonio Ceriello; Mustafa Cesur; Francesco Cosentino; Massimo Galia; Su-Yen Goh; Sanjay Kalra; Peter Kempler; Nader Lessan; Paulo Lotufo; Nikolaos Papanas; Ali A Rizvi; Raul D Santos; Anca P Stoian; Peter P Toth; Vijay Viswanathan; Manfredi Rizzo
Journal:  Int J Mol Sci       Date:  2022-06-30       Impact factor: 6.208

Review 3.  The New Entity of Subacute Thyroiditis amid the COVID-19 Pandemic: From Infection to Vaccine.

Authors:  Mihaela Popescu; Adina Ghemigian; Corina Maria Vasile; Andrei Costache; Mara Carsote; Alice Elena Ghenea
Journal:  Diagnostics (Basel)       Date:  2022-04-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.